Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • Authors & Reviewers
    • Overview for Authors
    • Preparing manuscripts
    • Submission Checklist
    • Publication Fees
    • Forms
    • Editorial Policies
    • Editorial Process
    • Patient-Oriented Research
    • Submit a manuscript
    • Manuscript Progress
    • Submitting a letter
    • Information for Reviewers
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • Authors & Reviewers
    • Overview for Authors
    • Preparing manuscripts
    • Submission Checklist
    • Publication Fees
    • Forms
    • Editorial Policies
    • Editorial Process
    • Patient-Oriented Research
    • Submit a manuscript
    • Manuscript Progress
    • Submitting a letter
    • Information for Reviewers
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow CMAJ Open on Twitter
Research
Open Access

Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series

Carl Boodman, Terence Wuerz, Philippe Lagacé-Wiens, Robbin Lindsay, Antonia Dibernardo, Jared Bullard, Derek R. Stein and Yoav Keynan
May 31, 2022 10 (2) E476-E482; DOI: https://doi.org/10.9778/cmajo.20210180
Carl Boodman
Section of Infectious Diseases (Boodman, Wuerz, Keynan), Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Departments of Medical Microbiology and Infectious Diseases (Boodman, Lagacé-Wiens, Bullard, Stein, Keynan) and Community Health Sciences (Wuerz), Max Rady College of Medicine, University of Manitoba; Shared Health (Lagacé-Wiens); National Microbiology Laboratory (Lindsay, Dibernardo); Cadham Provincial Laboratory (Bullard, Stein), Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terence Wuerz
Section of Infectious Diseases (Boodman, Wuerz, Keynan), Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Departments of Medical Microbiology and Infectious Diseases (Boodman, Lagacé-Wiens, Bullard, Stein, Keynan) and Community Health Sciences (Wuerz), Max Rady College of Medicine, University of Manitoba; Shared Health (Lagacé-Wiens); National Microbiology Laboratory (Lindsay, Dibernardo); Cadham Provincial Laboratory (Bullard, Stein), Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Lagacé-Wiens
Section of Infectious Diseases (Boodman, Wuerz, Keynan), Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Departments of Medical Microbiology and Infectious Diseases (Boodman, Lagacé-Wiens, Bullard, Stein, Keynan) and Community Health Sciences (Wuerz), Max Rady College of Medicine, University of Manitoba; Shared Health (Lagacé-Wiens); National Microbiology Laboratory (Lindsay, Dibernardo); Cadham Provincial Laboratory (Bullard, Stein), Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robbin Lindsay
Section of Infectious Diseases (Boodman, Wuerz, Keynan), Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Departments of Medical Microbiology and Infectious Diseases (Boodman, Lagacé-Wiens, Bullard, Stein, Keynan) and Community Health Sciences (Wuerz), Max Rady College of Medicine, University of Manitoba; Shared Health (Lagacé-Wiens); National Microbiology Laboratory (Lindsay, Dibernardo); Cadham Provincial Laboratory (Bullard, Stein), Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonia Dibernardo
Section of Infectious Diseases (Boodman, Wuerz, Keynan), Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Departments of Medical Microbiology and Infectious Diseases (Boodman, Lagacé-Wiens, Bullard, Stein, Keynan) and Community Health Sciences (Wuerz), Max Rady College of Medicine, University of Manitoba; Shared Health (Lagacé-Wiens); National Microbiology Laboratory (Lindsay, Dibernardo); Cadham Provincial Laboratory (Bullard, Stein), Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jared Bullard
Section of Infectious Diseases (Boodman, Wuerz, Keynan), Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Departments of Medical Microbiology and Infectious Diseases (Boodman, Lagacé-Wiens, Bullard, Stein, Keynan) and Community Health Sciences (Wuerz), Max Rady College of Medicine, University of Manitoba; Shared Health (Lagacé-Wiens); National Microbiology Laboratory (Lindsay, Dibernardo); Cadham Provincial Laboratory (Bullard, Stein), Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek R. Stein
Section of Infectious Diseases (Boodman, Wuerz, Keynan), Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Departments of Medical Microbiology and Infectious Diseases (Boodman, Lagacé-Wiens, Bullard, Stein, Keynan) and Community Health Sciences (Wuerz), Max Rady College of Medicine, University of Manitoba; Shared Health (Lagacé-Wiens); National Microbiology Laboratory (Lindsay, Dibernardo); Cadham Provincial Laboratory (Bullard, Stein), Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoav Keynan
Section of Infectious Diseases (Boodman, Wuerz, Keynan), Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Departments of Medical Microbiology and Infectious Diseases (Boodman, Lagacé-Wiens, Bullard, Stein, Keynan) and Community Health Sciences (Wuerz), Max Rady College of Medicine, University of Manitoba; Shared Health (Lagacé-Wiens); National Microbiology Laboratory (Lindsay, Dibernardo); Cadham Provincial Laboratory (Bullard, Stein), Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Abstract

Background: Bartonella are gram-negative bacilli not identified by routine bacterial culture. The objectives of this study were to review the results of all serologic testing for Bartonella ordered in Manitoba, Canada, and to review cases with positive test results among adults to assess species identification, risk factors, clinical manifestations and outcomes.

Methods: This retrospective study included all Bartonella serologic tests ordered in Manitoba and performed at the National Microbiology Laboratory, Winnipeg, from Jan. 1, 2010, until Dec. 31, 2020. We analyzed the aggregate data for all serologic tests for Bartonella for patients of all ages. We reviewed the charts of adult (age ≥ 18 yr) patients with serologic positivity for Bartonella who had a medical chart at 1 of Winnipeg’s 2 largest hospitals (Health Sciences Centre and St. Boniface Hospital) to extract clinical and demographic data and create a case series. Descriptive statistics were performed.

Results: During the study period, 1014 Bartonella serologic tests were ordered in adult and pediatric patients, of which 24 (2.4%) gave a positive result. Sixteen adults (12 men and 4 women; mean age 48 yr) seen at a participating hospital had a positive result. Molecular species-level identification occurred on explanted cardiac valves in 5 (31%) of the 16 cases; B. quintana was identified in all 5. Six patients (38%) were diagnosed with probable B. quintana infection, for a total of 11 B. quintana cases (69%); 8 (73%) of the 11 had endocarditis. Four cases of B. quintana infection (36%) were associated with rural residence. Four cases (25%) of probable B. henselae were identified; 2 patients had fever and lymphadenopathy, and 2 had endocarditis. The remaining patient was deemed to have a false-positive result as his B. henselae titre was at the threshold for positivity, his B. quintana serologic test gave a negative result, and his clinical syndrome was not suggestive of Bartonella infection. Two patients died; both had multivalvular B. quintana endocarditis with ruptured intracranial mycotic aneurysms.

Interpretation: Bartonella quintana was a common cause of Bartonella serologic positivity among adults in Manitoba in 2010–2020 and was associated with endocarditis and systemic embolization. As B. quintana is transmitted by body lice, active case finding for people who lack suitable housing, both in urban and rural settings, should prioritize those with elevated Bartonella titres to receive echocardiography and detect endocarditis before systemic embolization occurs.

Bartonella are gram-negative intra-erythrocytic bacilli.1,2 This genus of bacteria evades identification by routine culture owing to its slow replication time and niche within erythrocytes.3,4 Although more than 45 Bartonella species and subspecies infect various mammals, human disease due to Bartonella in North America is caused primarily by 2 species: B. henselae (cat scratch disease) and B. quintana (trench fever).2,5 Cat scratch disease usually occurs after a feline scratch or bite.6,7 Its most common clinical manifestation is regional lymphadenopathy.7 Bartonella quintana is transmitted in the feces of body lice, entering the systemic circulation via abrasions in the skin.8–10 Body lice live on clothing and bedding (Figure 1, Figure 2) and feed intermittently on the human host.8,10,11

Figure 1:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1:

Long underwear stained with human blood due to body lice ectoparasitosis acquired in Winnipeg, Canada.

Figure 2:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2:

Body lice, Pediculus humanus humanus, seen on clothing acquired from a patient experiencing houselessness in Winnipeg.

Clinical disease due to B. quintana was first described in 1915 among World War I soldiers and was thus coined “trench fever.”12 Although B. quintana was historically associated with a relapsing febrile illness, chronic bacteremia with B. quintana may be associated with few to no symptoms.12,13 Infection with B. quintana has since emerged among urban populations experiencing houselessness owing to infestations with body lice.8,9,14–17 Both B. henselae and B. quintana may cause endovascular infections such as infective endocarditis and mycotic aneurysms.18,19 Although patients with uncontrolled HIV infection may develop other manifestations of bartonellosis, such as bacillary angiomatosis and peliosis hepatis, most cases of Bartonella infection are not associated with HIV.20

Given the difficulties in identifying Bartonella with culture-based methods, serologic testing is often used to diagnose bartonellosis.2,3 A large diversity of clinical syndromes, including lymphadenopathy after a cat scratch, vegetations seen on echocardiography, visual loss due to possible infectious causes and febrile illness with negative culture results, prompt ordering of Bartonella serologic testing. Clear documentation of what prompted ordering testing is sometimes lacking.

In Canada, serologic evidence of exposure to B. henselae is common, reflecting local endemicity.21 Although Canadian data regarding other zoonotic Bartonella species are scant, serologic positivity for B. tribocorum, a species associated with rats,22 was described among people who inject drugs in Vancouver’s Downtown Eastside.23 Human infection with B. tribocorum is very rare;24 to our knowledge, no Canadian cases of clinical disease have been reported. The first Canadian case of B. quintana infection was described in 1996.25 Twenty years elapsed before a subsequent case was identified, in 2016.26 Since 2018, 6 cases of B. quintana infection have been described in Canada, from both inner-city and rural areas of Alberta and Manitoba.27–29 All cases were associated with endocarditis, a rare and severe manifestation of B. quintana infection, which suggests an undescribed burden of community transmission.30

As bartonellosis is not a reportable disease, little is known about Bartonella infection in Canada.31 The objectives of this study were to review the results of all serologic testing for Bartonella ordered in Manitoba from 2010 to 2020, and to review cases with positive test results to assess speciation, risk factors, clinical manifestations and outcomes.

Methods

Study design and setting

This study was a case series of adults with serologic positivity for Bartonella in Manitoba. Aggregate data included all serologic tests for Bartonella ordered from 2010 to 2020 for patients of all ages. We reviewed the charts of adult patients with positive test results to extract clinical and demographic data and to create a case series. We reported this study using the Preferred Reporting of Case Series in Surgery (PROCESS) guidelines.32

Participants

Inclusion criteria for chart review were age 18 years or more at the time of testing, serologic positivity for Bartonella and having a medical chart at 1 of Winnipeg’s 2 largest hospitals (Health Sciences Centre and St. Boniface Hospital). Pediatric cases were not included in the chart review owing to ethics approval considerations.

Data sources

We obtained the results of all serologic tests for Bartonella ordered in Manitoba from Jan. 1, 2010, until Dec. 31, 2020, from the database of Cadham Provincial Laboratory, Manitoba’s provincial public health laboratory, in Winnipeg. Bartonella serologic testing was performed at the National Microbiology Laboratory, Winnipeg. An indirect immunofluorescent antibody assay was used to test for immunoglobulin G antibodies to B. henselae and B. quintana antigen.33 A positive test result was defined as a titre of 1:256 or greater.33 Titres of 1:64 and 1:128 were considered equivocal, and titres less than 1:64 were considered negative.33 Before 2017, the National Microbiology Laboratory reported results of Bartonella serologic testing exclusively for B. henselae. There is known serologic cross-reactivity between B. henselae and B. quintana.2,34

C.B. and Y.K. retrospectively reviewed the electronic medical records and paper charts of adults who had positive results of Bartonella serologic testing, and extracted clinical, laboratory and demographic data from emergency department visits and hospital admissions to the Health Sciences Centre and St. Boniface Hospital (Appendix 1, available at www.cmajopen.ca/content/10/2/E476/suppl/DC1). Records were reviewed for the period 2 years before and 1 year after the serologic testing result. Clinical data included comorbidities, housing status, animal exposures, clinical syndrome, treatment and outcome. Laboratory data included B. quintana and B. henselae serologic titres and molecular speciation, if applicable. Demographic data included age, gender and geographic area based on home postal code.

Case definitions

We classified cases as confirmed or probable B. quintana or B. henselae infection by extrapolating from definitions of infections under public health surveillance.35 Confirmed cases had molecular confirmation to species level by means of 16S rRNA sequencing, species-specific polymerase chain reaction or gene sequencing. Patients with probable infection showed Bartonella positivity on serologic testing, compatible clinical syndrome and risk factors consistent with B. henselae or B. quintana acquisition, without molecular confirmation. Epidemiologic risk factors differ between B. henselae and B. quintana infection:16,36 B. henselae infection is associated with cat exposure, whereas B. quintana infection is associated with houselessness and body lice ectoparasitosis.36 Cases with low-grade serologic positivity but failure to fulfill the criteria for compatible clinical syndrome and epidemiologic risk factor were considered to have a false-positive result. Given the lack of suitable housing in many communities in northern Manitoba, we considered residence in a remote area known to have inadequate housing without a description of feline exposure a risk factor for B. quintana infection.26–28,37

Statistical analysis

We classified the aggregate data, which included data for both pediatric and adult patients, according to positive, equivocal or negative result of serologic testing for Bartonella. We performed descriptive statistics using R Statistical Software, version 3.5.3 (R Foundation for Statistical Computing).

Ethics approval

The study was approved by the University of Manitoba Bannatyne Campus Health Research Ethics Board (H2020:374), the Health Sciences Centre Research Ethics Board (RI2020: 147), St. Boniface Hospital’s Research Review Committee (RRC/2020/1978), Shared Health and Winnipeg Regional Health Authority’s Research Access and Approval Committee (2020-059) and the Manitoba Health Information Privacy Committee (2020/2021-79).

Results

During the study period, 1014 Bartonella serologic tests were ordered for adult and pediatric patients, of which 896 (88.4%) gave a negative result, 94 (9.3%) gave an equivocal result, and 24 (2.4%) gave a positive result (Table 1).

View this table:
  • View inline
  • View popup
Table 1:

Results of Bartonella serologic tests ordered in Manitoba, 2010–2020*

There were 16 adults (12 men and 4 women; mean age 48 yr) who had positive test results and received care at a participating hospital (Table 2). Twelve of the 16 patients lived in Winnipeg, and 4 cases of infection (all with B. quintana) were associated with rural geography: 3 patients resided in northern Manitoba, and 1 lived in Nunavut. One case of B. quintana infection was acquired in Eritrea before immigration. Two cases of B. henselae were acquired in Winnipeg, and 2 cases were acquired internationally. Of the 7 patients who acquired B. quintana infection in Winnipeg, 6 experienced a lack of suitable housing. Overall, 3 people were experiencing houselessness at the time of Bartonella testing, 4 lived in single rooms, and 2 depended on shelters for food and clothing. Although 3 of the 4 patients from northern communities were housed, 2 did not have running water, which indicated a lack of suitable housing.38

View this table:
  • View inline
  • View popup
Table 2:

Demographic characteristics of adults who had serologic positivity for Bartonella and received care at a participating hospital

Causative pathogen and clinical manifestations

Molecular species-level identification occurred on explanted cardiac valves in 5 cases (31%); the pathogen was B. quintana in all 5 (Table 3). Six patients (38%) were diagnosed with probable B. quintana infection, for a total of 11 B. quintana cases (69%). People infected with B. quintana described infestation with “bedbugs” and “itchy bugs” but not body lice per se. Of the 11 cases, 8 (73%) were associated with endocarditis. Seven (88%) of the 8 patients had evidence of embolization: 4 showed intracranial complications with embolization or ruptured mycotic aneurysms or both, and 3 had evidence of splenic infarcts. Mitral and aortic valve involvement was most common. Among cases of endocarditis with documented vegetation size, the average size was 17 mm × 7 mm. All cases of B. quintana endocarditis were associated with elevated Bartonella titres (> 1:1024). Two patients with B. quintana endocarditis had concomitant Streptococcus pneumoniae bacteremia.

View this table:
  • View inline
  • View popup
Table 3:

Clinical characteristics and outcomes of adults with serologic positivity for Bartonella

Four cases (25%) of probable B. henselae infection were identified. All 4 patients had a history of a cat scratch, 2 had fever and lymphadenopathy, and 2 had endocarditis. Patient 8 was deemed to have a false-positive result as his B. henselae titre was at the threshold for positivity, his B. quintana serologic test gave a negative result, and his clinical syndrome was not suggestive of Bartonella infection.

Comorbidities

Three patients (19%) were living with HIV infection, and 3 were coinfected with hepatitis C virus (Table 2). Two patients had previous valvular disease, rheumatic heart disease in 1 and a patent ductus arteriosus in the other. Three (27%) of the 11 patients infected with B. quintana had a description of ectoparasitosis in their medical chart. Ten patients (62%) had alcohol listed in their substance use history, and 6 (38%) had previous emergency department visits for withdrawal or intoxication. Four patients (25%) had a history of intravenous injection of crystal methamphetamine.

Treatment and outcome

Six patients (38%) underwent valve replacement surgery, and 2 patients (12%) underwent intravascular coiling of a middle cerebral artery aneurysm (Table 3). All patients with endocarditis were prescribed antimicrobial therapy; doxycycline + gentamicin, or ceftriaxone, or both, were the most common regimens. One patient was prescribed doxycycline and rifampin. Patients diagnosed with cat scratch disease were treated with azithromycin.

Fourteen patients (88%) survived. The 2 patients who died had multivalvular B. quintana endocarditis with ruptured intracranial mycotic aneurysms.

Interpretation

Bartonella quintana was a common cause of Bartonella serologic positivity among adults in Manitoba from 2010 to 2020. As B. quintana infection is transmitted by body lice, it is inherently tied to access to suitable housing and running water. The presence of B. quintana infection in urban and rural Manitoba indicates extreme conditions of privation, mimicking the trenches of World War I.39

It is unknown how many people with Bartonella serologic positivity will develop endocarditis. Data from an outbreak of B. quintana infection among people experiencing houselessness in Seattle suggest that endocarditis will develop in 20% of people with bacteremia due to B. quintana.30 Considering that only a minority of people with Bartonella serologic positivity are bacteremic, the elevated frequency of endocarditis in our study, 62%, suggests a substantial burden of undiagnosed trench fever in Manitoba.15

Endocarditis was present in 10 of our 16 patients. Of the 10 cases, 8 were due to B. quintana and 2 to B. henselae. Endocarditis due to B. quintana predominantly involved the mitral and aortic valves, as described previously.40,41 Embolization, including intracranial complications, was present in 7 of the 8 cases of B. quintana endocarditis. As embolization is not a salient feature of other reports, our cases may reflect a prolonged time to diagnosis and thus a greater burden of disease with higher propensity to embolize.18,40

Two cases of B. quintana endocarditis were associated with concomitant S. pneumoniae bacteremia. To our knowledge, only 1 other case of polymicrobial B. quintana endocarditis has been described, with Staphylococcus aureus.42 The presence of gram-positive cocci on the gram stain of patient 16’s explanted valve suggests acute on subacute endocarditis: subacute B. quintana infection creates valvular damage and large vegetations, which provide a substrate for seeding when acute bacteremia occurs with a different pathogen.

Bartonella serologic positivity was identified predominantly in men in our study, a finding described elsewhere.14,16 This may reflect the disproportional number of cases due to B. quintana and the known preponderance of men within the population experiencing houselessness in Canada.43 Although the association of B. quintana with alcohol use is well established, the association with intravenous crystal methamphetamine use has rarely been described.14 A Baltimore-based study showed that 37.5% of people who used intravenous drugs had serologic positivity for Bartonella.14 As the subacute bacteremia due to B. quintana may last many months, it is possible that B. quintana may be transmitted by shared syringes in addition to body lice ectoparasitosis.15 Although ectoparasitosis was described in the medical charts of 3 patients infected with B. quintana in our study, body lice were not mentioned explicitly in the charts. People infected with B. quintana described infestation with “bedbugs” and “itchy bugs” but not body lice per se. This may reflect a lack of familiarity with body lice ectoparasitosis among health care providers as well as people who are underhoused.

Of the 4 patients who had a history of injecting crystal methamphetamine, 3 were living with HIV infection, and 2 were coinfected with hepatitis C virus. The association of Bartonella infection with HIV infection, hepatitis C and intravenous stimulant use exemplifies a convergence of houselessness, substance use and infection described by the syndemic theory of disease.44

In this study, 3 cases of Bartonella infection were likely acquired in rural Manitoba and 1 in Nunavut. The association of B. quintana with urban houselessness is well-established, leading to the designation of “urban trench fever.”17 However, rural transmission of B. quintana is largely underrecognized. A recent case from northern Alberta suggests a hidden endemicity of B. quintana and body lice ectoparasitosis in remote communities in Canada.27 Local transmission of B. quintana in northern Manitoba, northern Alberta and Nunavut reflects the ongoing lack of suitable housing and running water within many Indigenous communities throughout Canada.37

To understand the full burden of B. quintana in Manitoba, seroprevalence and ectoparasite surveillance studies are necessary. Patients with elevated Bartonella titres should then undergo echocardiography to identify endocarditis before valvular damage or mycotic aneurysms develop. To prevent additional cases of B. quintana, a program sponsored by government and directed by the Indigenous community is needed to provide suitable housing and washing facilities in both inner-city Winnipeg and many remote communities. A similar Indigenous-rights approach has been proposed to curb rheumatic heart disease among Indigenous people in Canada, Australia and New Zealand.45 The establishment of accessible washing and laundry facilities is a necessary measure that can be implemented immediately to interrupt B. quintana transmission.39 Finally, including B. quintana among the list of nationally and provincially notifiable diseases could serve as a flagship diagnosis to reflect the state of housing accessibility in Canada.31

Limitations

This study is limited by the known serologic cross-reactivity between different Bartonella species and other infectious pathogens, albeit at lower titres.46 Occasional cases of Bartonella bacteremia and endocarditis have been associated with negative results of serologic testing for Bartonella despite molecular confirmation of Bartonella.15 Although all 16 adults with serologic positivity for Bartonella in our study had medical records at Manitoba’s 2 largest hospitals, limiting our chart review to these 2 facilities may have limited information regarding milder clinical manifestations.

Conclusion

Bartonella quintana was a common cause of Bartonella serologic positivity among adults in Manitoba in 2010–2020 and was associated with endocarditis and systemic embolization. The presence of B. quintana infection in urban and rural Manitoba indicates the need for improved access to suitable housing and running water, both in inner-city Winnipeg and in remote Manitoba communities. Improved case finding through seroprevalence studies and subsequent echocardiographic surveillance for people with elevated Bartonella titres are needed to prevent endovascular complications such as endocarditis and mycotic aneurysm rupture.

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

  • Contributors: Carl Boodman and Yoav Keynan conceived the study and analyzed the data. Carl Boodman, Terence Wuerz and Yoav Keynan designed the study. Carl Boodman, Jared Bullard and Derek Stein acquired the data. Carl Boodman and Yoav Keynan interpreted the data, with assistance from Philippe Lagacé-Wiens, Robbin Lindsay and Antonia Dibernardo. Carl Boodman drafted the manuscript, and Terence Wuerz, Philippe Lagacé-Wiens, Robbin Lindsay, Antonia Dibernardo, Jared Bullard, Derek Stein and Yoav Keynan revised it critically for important intellectual content. All of the authors approved the final version to be published and agreed to be accountable for all aspects of the work.

  • Funding: This work was supported by the Dr. Hector Ma Award in Research in Internal Medicine, University of Manitoba.

  • Data sharing: No additional data will be available to other researchers, in order to protect the personally identifiable information of the participants. Questions about the article or the data may be sent to the corresponding author.

  • Supplemental information: For reviewer comments and the original submission of this manuscript, please see www.cmajopen.ca/content/10/2/E476/suppl/DC1.

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

References

  1. ↵
    1. Foucault C,
    2. Brouqui P,
    3. Raoult D
    (2006) Bartonella quintana characteristics and clinical management. Emerg Infect Dis 12:217–23.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Okaro U,
    2. Addisu A,
    3. Casanas B,
    4. et al.
    (2017) Bartonella species, an emerging cause of blood-culture-negative endocarditis. Clin Microbiol Rev 30:709–46.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. La Scola B,
    2. Raoult D
    (1999) Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol 37:1899–905.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Lynch T,
    2. Iverson J,
    3. Kosoy M
    (2011) Combining culture techniques for Bartonella: the best of both worlds. J Clin Microbiol 49:1363–8.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Engel P,
    2. Salzburger W,
    3. Liesch M,
    4. et al.
    (2011) Parallel evolution of a type IV secretion system in radiating lineages of the host-restricted bacterial pathogen Bartonella. PLoS Genet 7:e1001296.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Koehler JE,
    2. Glaser CA,
    3. Tappero JW
    (1994) Rochalimaea henselae infection: a new zoonosis with the domestic cat as reservoir. JAMA 271:531–5.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Florin TA,
    2. Zaoutis TE,
    3. Zaoutis LB
    (2008) Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics 121:e1413–25.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Leibler JH,
    2. Zakhour CM,
    3. Gadhoke P,
    4. et al.
    (2016) Zoonotic and vector-borne infections among urban homeless and marginalized people in the United States and Europe, 1990–2014. Vector Borne Zoonotic Dis 16:435–44.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Raoult D,
    2. Foucault C,
    3. Brouqui P
    (2001) Infections in the homeless. Lancet Infect Dis 1:77–84.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Sangaré AK,
    2. Doumbo OK,
    3. Raoult D
    (2016) Management and treatment of human lice. BioMed Res Int 2016:8962685.
    OpenUrl
  11. ↵
    1. Badiaga S,
    2. Raoult D,
    3. Brouqui P
    (2008) Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerg Infect Dis 14:1353–9.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Graham JHP
    (1915) A note on a relapsing febrile illness of unknown origin. Lancet 186:703–4.
    OpenUrl
  13. ↵
    1. Brouqui P,
    2. Lascola B,
    3. Roux V,
    4. et al.
    (1999) Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med 340:184–9.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Comer JA,
    2. Flynn C,
    3. Regnery RL,
    4. et al.
    (1996) Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med 156:2491–5.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Foucault C,
    2. Barrau K,
    3. Brouqui P,
    4. et al.
    (2002) Bartonella quintana bacteremia among homeless people. Clin Infect Dis 35:684–9.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Brouqui P,
    2. Houpikian P,
    3. Dupont HT,
    4. et al.
    (1996) Survey of the seroprevalence of Bartonella quintana in homeless people. Clin Infect Dis 23:756–9.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Ohl ME,
    2. Spach DH
    (2000) Bartonella quintana and urban trench fever. Clin Infect Dis 31:131–5.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Edouard S,
    2. Nabet C,
    3. Lepidi H,
    4. et al.
    (2015) Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol 53:824–9.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Luciani L,
    2. El Baroudi Y,
    3. Prudent E,
    4. et al.
    (2021) Bartonella infections diagnosed in the French reference center, 2014–2019, and focus on infections in the immunocompromised. Eur J Clin Microbiol Infect Dis 40:2407–10.
    OpenUrl
  20. ↵
    1. Jackson LA,
    2. Spach DH,
    3. Kippen DA,
    4. et al.
    (1996) Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis 173:1023–6.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Cimolai N,
    2. Benoit L,
    3. Hill A,
    4. et al.
    (2000) Bartonella henselae infection in British Columbia: evidence for an endemic disease among humans. Can J Microbiol 46:908–12.
    OpenUrlPubMed
  22. ↵
    1. Himsworth CG,
    2. Bai Y,
    3. Kosoy MY,
    4. et al.
    (2015) An investigation of Bartonella spp., Rickettsia typhi, and Seoul hantavirus in rats (Rattus spp.) from an inner-city neighborhood of Vancouver, Canada: Is pathogen presence a reflection of global and local rat population structure? Vector Borne Zoonotic Dis 15:21–6.
    OpenUrl
  23. ↵
    1. McVea DA,
    2. Himsworth CG,
    3. Patrick DM,
    4. et al.
    (2018) Exposure to rats and rat-associated Leptospira and Bartonella species among people who use drugs in an impoverished, inner-city neighborhood of Vancouver, Canada. Vector Borne Zoonotic Dis 18:82–8.
    OpenUrl
  24. ↵
    1. Kandelaki G,
    2. Malania L,
    3. Bai Y,
    4. et al.
    (2016) Human lymphadenopathy caused by rat-borne Bartonella, Tbilisi, Georgia. Emerg Infect Dis 22:544–6.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Raoult D,
    2. Fournier PE,
    3. Drancourt M,
    4. et al.
    (1996) Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 125:646–52.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Keynan Y,
    2. Mackenzie L,
    3. Lagacé-Wiens P
    (2016) Quintessential culture-negative endocarditis. Can J Cardiol 32:395e9–10.
    OpenUrl
  27. ↵
    1. Kleinman DR,
    2. Lam JC,
    3. Bacani J,
    4. et al.
    (2020) Bartonella quintana infective endocarditis in northern Alberta: a case report. JAMMI 5:256–60.
    OpenUrl
  28. ↵
    1. Boodman C,
    2. Wuerz T,
    3. Lagacé-Wiens P
    (2020) Endocarditis due to Bartonella quintana, the etiological agent of trench fever. CMAJ 192:E1723–6.
    OpenUrlFREE Full Text
  29. ↵
    1. Lam JC,
    2. Fonseca K,
    3. Pabbaraju K,
    4. et al.
    (2019) Case report: Bartonella quintana endocarditis outside of the Europe–African gradient: comprehensive review of cases within North America. Am J Trop Med Hyg 100:1125–9.
    OpenUrlCrossRef
  30. ↵
    1. Spach DH,
    2. Kanter AS,
    3. Dougherty MJ,
    4. et al.
    (1995) Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med 332:424–8.
    OpenUrlCrossRefPubMed
  31. ↵
    Case definitions: nationally notifiable diseases (Public Health Agency of Canada, Ottawa) modified 2021 July 20. Available: https://diseases.canada.ca/notifiable/diseases-list. accessed 2021 June 13.
  32. ↵
    1. Agha RA,
    2. Sohrabi C,
    3. Mathew G,
    4. et al.,
    5. PROCESS Group
    (2020) The PROCESS 2020 guideline: updating consensus Preferred Reporting Of CasESeries in Surgery (PROCESS) guidelines. Int J Surg 84:231–5.
    OpenUrl
  33. ↵
    (2011) Bartonella IFA IgG (OUS) [package insert] (Diagnostics FOCUS, Cypress (CA)) Available: https://www.focusdx.com/pdfs/pi/OUS/IF1300G-OUS.pdf. accessed 2021 June 15.
  34. ↵
    1. Dalton MJ,
    2. Robinson LE,
    3. Cooper J,
    4. et al.
    (1995) Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med 155:1670–6.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Centers for Disease Control and Prevention
    (1997) Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 46:1–55.
    OpenUrlPubMed
  36. ↵
    1. Fournier PE,
    2. Lelievre H,
    3. Eykyn SJ,
    4. et al.
    (2001) Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) 80:245–51.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Deegan CLA,
    2. Bonnycastle MM
    (2020) Displacement, housing and homelessness in northern Manitoba communities (Canadian Centre for Policy Alternatives Manitoba, Winnipeg) Available: https://www.policyalternatives.ca/sites/default/files/uploads/publications/ManitobaOffice/2020/11/NorthernHomelessness.pdf. accessed 2021 May 24.
  38. ↵
    (2017) Dictionary, census of population, 2016 housing suitability (Statistics Canada, Ottawa).
  39. ↵
    1. Houston SC
    (Jan 26, 2021) CMAJ, Lousy living conditions in Canadian cities [letter]. Available: https://www.cmaj.ca/content/re-lousy-living-conditions-canadian-cities. accessed 2021 Oct. 26.
  40. ↵
    1. Ghidey FY,
    2. Igbinosa O,
    3. Mills K,
    4. et al.
    (2016) Case series of Bartonella quintana blood culture-negative endocarditis in Washington, DC. JMM Case Rep 3:e005049.
    OpenUrl
  41. ↵
    1. Raoult D,
    2. Fournier PE,
    3. Vandenesch F,
    4. et al.
    (2003) Outcome and treatment of Bartonella endocarditis. Arch Intern Med 163:226–30.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Barbier F,
    2. Fournier PE,
    3. Dauge MC,
    4. et al.
    (2009) Bartonella quintana coinfection in Staphylococcus aureus endocarditis: Usefulness of screening in high-risk patients? Clin Infect Dis 48:1332–3.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Gaetz S,
    2. Dej E,
    3. Richter T,
    4. et al.
    (2016) The state of homelessness in Canada 2016 Canadian Observatory on Homelessness Research Paper #12 (Canadian Observatory on Homelessness Press, Toronto).
  44. ↵
    1. Singer M,
    2. Bulled N,
    3. Ostrach B,
    4. et al.
    (2017) Syndemics and the biosocial conception of health. Lancet 389:941–50.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Wyber R,
    2. Wade V,
    3. Anderson A,
    4. et al.
    (2021) Rheumatic heart disease in Indigenous young peoples. Lancet Child Adolesc Health 5:437–46.
    OpenUrl
  46. ↵
    1. La Scola B,
    2. Raoult D
    (1996) Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii. J Clin Microbiol 34:2270–4.
    OpenUrlAbstract/FREE Full Text
  • © 2022 CMA Impact Inc. or its licensors
PreviousNext
Back to top

In this issue

CMAJ Open: 10 (2)
Vol. 10, Issue 2
1 Apr 2022
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
Carl Boodman, Terence Wuerz, Philippe Lagacé-Wiens, Robbin Lindsay, Antonia Dibernardo, Jared Bullard, Derek R. Stein, Yoav Keynan
Apr 2022, 10 (2) E476-E482; DOI: 10.9778/cmajo.20210180

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
Carl Boodman, Terence Wuerz, Philippe Lagacé-Wiens, Robbin Lindsay, Antonia Dibernardo, Jared Bullard, Derek R. Stein, Yoav Keynan
Apr 2022, 10 (2) E476-E482; DOI: 10.9778/cmajo.20210180
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Evidence-based Medicine
      • Diagnostic tests
    • Infectious Diseases
      • Other infectious diseases
    • Public Health
      • Other public health
    • Vulnerable populations
  • Nonclinical
    • Epidemiology
      • Socioeconomic determinants of health

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Preparing manuscripts
  • Manuscript Submission Checklist
  • Publication Fees
  • Forms
  • Editorial Policies
  • Editorial Process
  • Patient-Oriented Research
  • Submit a manuscript
  • Manuscript Progress
  • Submitting a letter
  • Information for Reviewers

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Media
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

View CMA's Accessibility policy.

 

Powered by HighWire